Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Douer

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Blood|January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraSimon Mantha, Debra A Goldman, Sean M Devlin, et al.
Leukemia Research|June 18, 2013
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic deathJessica K Altman, Alfred Rademaker, Elizabeth Cull, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Acute lymphoblastic leukemiaJoseph C Alvarnas, Patrick A Brown, Patricia Aoun, et al.
Science Translational Medicine|February 21, 2014
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemiaMarco L Davila, Isabelle Riviere, Xiuyan Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Acute Lymphoblastic Leukemia, Version 2.2015Joseph C Alvarnas, Patrick A Brown, Patricia Aoun, et al.
Blood|January 29, 2011
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapseMark Levis, Farhad Ravandi, Eunice S Wang, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Blood|January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraSimon Mantha, Debra A Goldman, Sean M Devlin, et al.
Leukemia Research|June 18, 2013
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic deathJessica K Altman, Alfred Rademaker, Elizabeth Cull, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Acute lymphoblastic leukemiaJoseph C Alvarnas, Patrick A Brown, Patricia Aoun, et al.
Science Translational Medicine|February 21, 2014
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemiaMarco L Davila, Isabelle Riviere, Xiuyan Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Acute Lymphoblastic Leukemia, Version 2.2015Joseph C Alvarnas, Patrick A Brown, Patricia Aoun, et al.
Blood|January 29, 2011
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapseMark Levis, Farhad Ravandi, Eunice S Wang, et al.
Pageof 9